Literature DB >> 3774688

Muscular (hypertrophic) subaortic stenosis (hypertrophic obstructive cardiomyopathy): the evidence for true obstruction to left ventricular outflow.

E D Wigle, M Henderson, H Rakowski, S Wilansky.   

Abstract

The clinical and haemodynamic significance of the subaortic pressure gradient in patients with muscular (hypertrophic) subaortic stenosis (hypertrophic obstructive cardiomyopathy) has long been debated. In this report we summarize the evidence which indicates that true obstruction to left ventricular outflow exists in these patients. Rapid left ventricular ejection, through an outflow tract narrowed by ventricular septal hypertrophy, results in Venturi forces causing systolic anterior motion of the anterior (or posterior) mitral leaflets. Mitral leaflet-septal contact results in obstruction to outflow and the accompanying mitral regurgitation. The time of onset of mitral leaflet-septal contact determines the magnitude of the pressure gradient and the severity of the mitral regurgitation, as well as the degree of prolongation of left ventricular ejection time and the percentage of left ventricular stroke volume that is ejected in the presence of an obstructive pressure gradient. Early and prolonged mitral leaflet-septal contact results in a large pressure gradient, significant mitral regurgitation, as well as dramatic prolongation of the ejection time and a large percentage of left ventricular stroke volume being obstructed. Late and short mitral leaflet-septal contact results in little haemodynamic perturbation. Hypertrophic cardiomyopathy patients with obstructive pressure gradients are significantly more symptomatic than those without. Thus the obstructive pressure gradients in hypertrophic cardiomyopathy are of clinical as well as haemodynamic significance. To deny the existence of obstruction to outflow in patients with muscular subaortic stenosis is to deny these patients appropriate medical and surgical therapy.

Entities:  

Mesh:

Year:  1986        PMID: 3774688      PMCID: PMC2418801          DOI: 10.1136/pgmj.62.728.531

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  7 in total

1.  Muscular subaortic stenosis. The direct relation between the intraventricular pressure difference and the left ventricular ejection time.

Authors:  E D Wigle; P Auger; Y Marquis
Journal:  Circulation       Date:  1967-07       Impact factor: 29.690

Review 2.  The frontiers of cardiomyopathy.

Authors:  J F Goodwin
Journal:  Br Heart J       Date:  1982-07

3.  Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy.

Authors:  J P Murgo; B R Alter; J F Dorethy; S A Altobelli; G M McGranahan
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

4.  The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis.

Authors:  J Ross; E Braunwald; J H Gault; D T Mason; A G Morrow
Journal:  Circulation       Date:  1966-10       Impact factor: 29.690

5.  Muscular subaortic stenosis. Initial left ventricular inflow tract pressure in the assessment of intraventricular pressure differences in man.

Authors:  E D Wigle; Y Marquis; P Aucer
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

6.  Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography.

Authors:  B J Maron; J S Gottdiener; J Arce; D R Rosing; Y E Wesley; S E Epstein
Journal:  J Am Coll Cardiol       Date:  1985-07       Impact factor: 24.094

Review 7.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review.

Authors:  E D Wigle; Z Sasson; M A Henderson; T D Ruddy; J Fulop; H Rakowski; W G Williams
Journal:  Prog Cardiovasc Dis       Date:  1985 Jul-Aug       Impact factor: 8.194

  7 in total
  4 in total

1.  Ventricular dysfunction in hypertrophic obstructive cardiomyopathy.

Authors:  R D Leachman
Journal:  Tex Heart Inst J       Date:  1991

Review 2.  Surgical treatment for hypertrophic cardiomyopathy: a historical perspective.

Authors:  Dustin Hang; Anita Nguyen; Hartzell V Schaff
Journal:  Ann Cardiothorac Surg       Date:  2017-07

Review 3.  Percutaneous transluminal septal myocardial ablation.

Authors:  D N Rubin; E M Tuzcu; H M Lever
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 3.955

4.  Gradient variability in hypertrophic cardiomyopathy: New insights from computer-assisted, high fidelity, rest and exercise hemodynamic analysis.

Authors:  Terry D Bauch; Alexandra J Smith; Joseph P Murgo; James A Watts; Bernard J Rubal
Journal:  Catheter Cardiovasc Interv       Date:  2018-11-25       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.